GIHN || News

Nucleoside analogues’ benefits in HBV vary

Posted on: 01/07/2014 - 05:01

Nucleoside analogues are effective at preventing hepatocellular carcinoma in hepatitis B, but all are not equal when it comes to overall mortality and liver transplant, according to two new studies...

Field of Interest: Gastroentero...
Type: News Item

Serrated polyposis syndrome warrants annual screen

Posted on: 01/07/2014 - 05:01

Annual surveillance of serrated polyposis syndrome patients detected a relatively high rate of advanced adenomas and large serrated polyps, reported Dr. Yark Hazewinkel and colleagues in the July...

Field of Interest: Gastroentero...
Type: News Item

Aim for deep remission, high troughs in Crohn’s

Posted on: 01/03/2014 - 05:01

"Deep remission" of Crohn’s disease is associated with better quality of life, physical function, and cost savings. Moreover, this composite clinical and endoscopic endpoint may be best...

Field of Interest: Gastroentero...
Type: News Item

Fecal immunochemical tests detect most colorectal cancers

Posted on: 03/02/2014 - 22:00

Fecal immunochemical tests have an overall diagnostic accuracy of 95% for the detection of colorectal cancer, according to the results of a meta-analysis just published in the Annals of Internal...

Field of Interest: Oncology
Type: News Item

Low-FODMAP diet reduced IBS symptoms

Posted on: 01/01/2014 - 05:01

Diets low in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols reduced functional gastrointestinal symptoms in patients with irritable bowel syndrome. The finding, published...

Field of Interest: Gastroentero...
Type: News Item

Golimumab maintains response in UC

Posted on: 01/01/2014 - 05:01

Subcutaneous golimumab induces and maintains clinical response in ulcerative colitis, according to two studies in the January issue of Gastroenterology. <link...

Field of Interest: Gastroentero...
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More